PlainRecalls
FDA Drug Moderate Class II Terminated

Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01

Reported: November 2, 2016 Initiated: October 6, 2016 #D-0113-2017

Product Description

Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01

Reason for Recall

Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.

Details

Units Affected
2562 bottles
Distribution
Nationwide
Location
Ridgefield, CT

Frequently Asked Questions

What product was recalled?
Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01. Recalled by Boehringer Ingelheim Pharmaceuticals, Inc.. Units affected: 2562 bottles.
Why was this product recalled?
Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2016. Severity: Moderate. Recall number: D-0113-2017.